Additionally, WT1 expression has been identified and used as a potent transcriptional regulator and marker for myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and solid tumors, including breast carcinoma. The gene discussed is WT1; the disease is acute myeloid leukemia.